DELPHINE ROLLAND ET AL: "Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial", CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 65, no. 4, 4 December 2009 (2009-12-04), pages 781-790, XP019779242, ISSN: 1432-0843 (B9)

I. A. Prior ET AL: "A Comprehensive Survey of Ras Mutations in Cancer", Cancer research, vol. 72, no. 10, 14 May 2012 (2012-05-14), pages 2457-2467, XP055117242, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-11-2612 (B9)

JUAN JOSE PEREZ-RUIXO ET AL: "Exposure-toxicity relationships for tipifarnib in cancer patients", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY., vol. 64, no. 2, 1 August 2007 (2007-08-01) , pages 219-232, XP055494402, GB ISSN: 0306-5251, DOI: 10.1111/j.1365-2125.2007.02883.x (B9)

M H KIRSCHBAUM ET AL: "A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia", LEUKEMIA., vol. 25, no. 10, 31 May 2011 (2011-05-31), pages 1543-1547, XP055494386, US ISSN: 0887-6924, DOI: 10.1038/leu.2011.124 (B9)

OH S-H ET AL: "Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma", CLINICAL CANCER RESE, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 12, no. 2, 1 January 2006 (2006-01-01), pages 653-661, XP008106229, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-05-1725 (B9)

Yoshimasa Saito ET AL: "MicroRNAs in Hepatobiliary and Pancreatic Cancers", FRONTIERS IN GENETICS, vol. 2, 1 January 2011 (2011-01-01), XP055228584, Switzerland ISSN: 1664-8021, DOI: 10.3389/fgene.2011.00066 (B9)

WO-A1-2015/164862 (B9)

WO-A2-2012/016021 (B9)

X CHEN ET AL: "Transformation by HrasG12V is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition", ONCOGENE, vol. 33, no. 47, 18 November 2013 (2013-11-18), pages 5442-5449, XP055232606, GB ISSN: 0950-9232, DOI: 10.1038/onc.2013.489 (B9)

YAO R ET AL: "Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: Role of Ha-ras mutations and use of microarray analysis in identifying potential targets", CARCINOGENESIS 200607 GB, vol. 27, no. 7, July 2006 (2006-07), pages 1420-1431, XP002763821, ISSN: 0143-3334 (B9)

SHI YUQUAN ET AL: "Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survival", PROSTATE, vol. 62, no. 1, 1 January 2005 (2005-01-01), pages 69-82, XP002763822, ISSN: 0270-4137 (B9)